Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.

Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.

BACKGROUND: Only one-third of patients with depression respond fully to treatment with antidepressant medication. However, there is little robust evidence to guide the management of those whose symptoms are 'treatment resistant'. OBJECTIVE: The CoBalT trial examined the clinical effectiven...

Full description

Bibliographic Details
Main Authors: Wiles, N, Thomas, L, Abel, A, Barnes, M, Carroll, F, Ridgway, N, Sherlock, S, Turner, N, Button, K, Odondi, L, Metcalfe, C, Owen-Smith, A, Campbell, J, Garland, A, Hollinghurst, S, Jerrom, B, Kessler, D, Kuyken, W, Morrison, J, Turner, K, Williams, C, Peters, T, Lewis, G
Format: Journal article
Language:English
Published: National Co-ordinating Centre for HTA 2014

Similar Items

Similar Items